Literature DB >> 20507952

N-terminal proBNP--marker of cardiac dysfunction, fluid overload, or malnutrition in hemodialysis patients?

John Booth1, Jennifer Pinney, Andrew Davenport.   

Abstract

BACKGROUND AND OBJECTIVES: N-terminal probrain type natriuretic peptide (NTproBNP) has been proven to be a valuable biomarker for predicting cardiac events and mortality in the hemodialysis population. However recent reports have suggested that NTproBNP is a marker of volume overload rather than one of cardiac dysfunction. Therefore this study investigated the effect of fluid volume status on NTproBNP. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Volume status was determined pre- and postdialysis in 72 stable hemodialysis outpatients by multifrequency bioimpedance, and the relationship to NTproBNP values was examined.
RESULTS: The mean and median NTproBNP values were 931.9 +/- 230 and 242 (90 to 688) pmol/L, respectively. On simple correlation, NTproBNP was associated with markers of volume overload and cardiac dysfunction. However, on logistical regression analysis, the strongest association was with the predialysis ratio of extracellular water/total body water (beta 26.6, F29.6, P = 0.000), followed by postdialysis mean arterial blood pressure (beta 0.14, F17.1, P = 0.000), dialysate calcium concentration (beta -1.19, F14.1, P = 0.002), and change in extracellular fluid volume with dialysis (beta 0.27, F7.4, P = 0.009)
CONCLUSIONS: In this study, NTproBNP was not associated with cardiac dysfunction as assessed by transthoracic echo or nuclear medicine scintigraphy but was dependent on factors associated with volume overload. However, because bioimpedance results can also be affected by malnutrition with loss of cell mass, NTproBNP may be elevated not only in patients with volume overload, but also those with malnutrition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20507952      PMCID: PMC2879314          DOI: 10.2215/CJN.09001209

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  20 in total

1.  Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis.

Authors:  Takatoshi Goto; Hiroyuki Takase; Takayuki Toriyama; Tomonori Sugiura; Yutaka Kurita; Nobuo Tsuru; Hiroaki Masuda; Kunihiko Hayashi; Ryuzo Ueda; Yasuki Dohi
Journal:  Nephron       Date:  2002       Impact factor: 2.847

2.  Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.

Authors:  G Metry; C Hall; B Wikström; V Källskog; P Hansell; B Danielson
Journal:  Acta Physiol Scand       Date:  2001-02

3.  Association between serum n-terminal pro-brain natriuretic peptide concentration and left ventricular dysfunction and extracellular water in continuous ambulatory peritoneal dialysis patients.

Authors:  Jung-Ahn Lee; Do-Hyoung Kim; Soo-Jeong Yoo; Dong-Jin Oh; Suk-Hee Yu; Eung-Tack Kang
Journal:  Perit Dial Int       Date:  2006 May-Jun       Impact factor: 1.756

4.  Are natriuretic peptides useful biomarkers in dialysis patients?

Authors:  Jos J van den Kerkhof; Frank M Van der Sande; Karel Leunissen; Jeroen P Kooman
Journal:  Perit Dial Int       Date:  2007 Nov-Dec       Impact factor: 1.756

5.  Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.

Authors:  Sascha David; Philipp Kümpers; Vega Seidler; Frank Biertz; Hermann Haller; Danilo Fliser
Journal:  Nephrol Dial Transplant       Date:  2007-12-18       Impact factor: 5.992

6.  The prognostic role of brain natriuretic peptides in hemodialysis patients.

Authors:  Toshihide Naganuma; Kazunobu Sugimura; Seiji Wada; Ryoji Yasumoto; Takeshi Sugimura; Chikayoshi Masuda; Junji Uchida; Tatuya Nakatani
Journal:  Am J Nephrol       Date:  2002 Sep-Dec       Impact factor: 3.754

7.  N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis.

Authors:  L H Madsen; S Ladefoged; P Corell; M Schou; P R Hildebrandt; D Atar
Journal:  Kidney Int       Date:  2007-02-14       Impact factor: 10.612

8.  The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease.

Authors:  Victoria Sheen; Vikas Bhalla; Alisi Tulua-Tata; Meenakshi A Bhalla; Danielle Weiss; Albert Chiu; Omaran Abdeen; Scott Mullaney; Alan Maisel
Journal:  Am Heart J       Date:  2007-02       Impact factor: 4.749

Review 9.  Cardiovascular disease and mortality in ESRD.

Authors:  R N Foley; P S Parfrey
Journal:  J Nephrol       Date:  1998 Sep-Oct       Impact factor: 3.902

10.  Association between brain natriuretic peptide and extracellular water in hemodialysis patients.

Authors:  Riccardo Maria Fagugli; Barbara Palumbo; Daniela Ricciardi; Paolo Pasini; Paola Santirosi; Luigi Vecchi; Franca Pasticci; Renato Palumbo
Journal:  Nephron Clin Pract       Date:  2003
View more
  48 in total

1.  Can non-invasive measurements aid clinical assessment of volume in patients with cirrhosis?

Authors:  Andrew Davenport; Banwari Argawal; Gavin Wright; Konstantinos Mantzoukis; Rumyana Dimitrova; Joseph Davar; Panayota Vasianopoulou; Andrew K Burroughs
Journal:  World J Hepatol       Date:  2013-08-27

2.  Screening for muscle loss in patients established on peritoneal dialysis using bioimpedance.

Authors:  G H B Greenhall; A Davenport
Journal:  Eur J Clin Nutr       Date:  2016-10-26       Impact factor: 4.016

3.  Associations between bioelectrical impedance parameters and cardiovascular events in chronic dialysis patients.

Authors:  Aline de Araujo Antunes; Francieli Delatim Vannini; Liciana Vaz de Arruda Silveira; Pasqual Barretti; Luis Cuadrado Martin; Jacqueline Costa Teixeira Caramori
Journal:  Int Urol Nephrol       Date:  2012-12-04       Impact factor: 2.370

4.  Brain Natriuretic Peptide and Body Fluid Composition in Patients with Chronic Kidney Disease: A Cross-Sectional Study to Evaluate the Relationship between Volume Overload and Malnutrition.

Authors:  Yasushi Ohashi; Akinobu Saito; Keisuke Yamazaki; Reibin Tai; Tatsuru Matsukiyo; Atsushi Aikawa; Ken Sakai
Journal:  Cardiorenal Med       Date:  2016-06-23       Impact factor: 2.041

5.  Is overhydration in peritoneal dialysis patients associated with cardiac mortality that might be reversible?

Authors:  Elizabeth Oei; Klara Paudel; Annemarie Visser; Hazel Finney; Stanley L Fan
Journal:  World J Nephrol       Date:  2016-09-06

6.  Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis.

Authors:  Wacharee Seeherunvong; Carolyn L Abitbol; Jayanthi Chandar; Paolo Rusconi; Gaston E Zilleruelo; Michael Freundlich
Journal:  Pediatr Nephrol       Date:  2012-06-19       Impact factor: 3.714

7.  N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients.

Authors:  Magid A Fahim; Andrew Hayen; Andrea R Horvath; Goce Dimeski; Amanda Coburn; David W Johnson; Carmel M Hawley; Scott B Campbell; Jonathan C Craig
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-24       Impact factor: 8.237

8.  B-type natriuretic peptide is not a volume marker among patients on hemodialysis.

Authors:  Rajiv Agarwal
Journal:  Nephrol Dial Transplant       Date:  2013-03-22       Impact factor: 5.992

9.  Aortic pulse wave velocity in haemodialysis patients is associated with the prescription of active vitamin D analogues.

Authors:  Evangelina Charitaki; Andrew Davenport
Journal:  J Nephrol       Date:  2014-01-29       Impact factor: 3.902

10.  DETERMINATION OF VOLUME OVERLOAD BY BIOELECTRICAL IMPEDANCE ANALYSIS AND NT-PROBNP IN DIABETIC PRE-DIALYSIS PATIENTS.

Authors:  Y Yildirim; A V Kara; F Kilinç; F Aydin; E Aydin; Z Yilmaz; A K Kadiroglu; M E Yilmaz
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jan-Mar       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.